These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19438609)

  • 41. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes.
    Wang S; Zhang M; Liang B; Xu J; Xie Z; Liu C; Viollet B; Yan D; Zou MH
    Circ Res; 2010 Apr; 106(6):1117-28. PubMed ID: 20167927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of AMP-activated protein kinase accentuates lipopolysaccharide-induced lung endothelial barrier dysfunction and lung injury in vivo.
    Xing J; Wang Q; Coughlan K; Viollet B; Moriasi C; Zou MH
    Am J Pathol; 2013 Mar; 182(3):1021-30. PubMed ID: 23306156
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
    Oki K; Arias EB; Kanzaki M; Cartee GD
    Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
    Rattan R; Giri S; Singh AK; Singh I
    J Biol Chem; 2005 Nov; 280(47):39582-93. PubMed ID: 16176927
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury.
    Zhao X; Zmijewski JW; Lorne E; Liu G; Park YJ; Tsuruta Y; Abraham E
    Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L497-504. PubMed ID: 18586954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of AMP-activated protein kinase stimulates the nuclear localization of glyceraldehyde 3-phosphate dehydrogenase in human diploid fibroblasts.
    Kwon HJ; Rhim JH; Jang IS; Kim GE; Park SC; Yeo EJ
    Exp Mol Med; 2010 Apr; 42(4):254-69. PubMed ID: 20177150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).
    Nerstedt A; Johansson A; Andersson CX; Cansby E; Smith U; Mahlapuu M
    Diabetologia; 2010 Nov; 53(11):2406-16. PubMed ID: 20652679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes.
    Campàs C; Lopez JM; Santidrián AF; Barragán M; Bellosillo B; Colomer D; Gil J
    Blood; 2003 May; 101(9):3674-80. PubMed ID: 12522004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms underpinning AMP-activated protein kinase-related effects on behavior and hippocampal neurogenesis in an animal model of depression.
    Odaira T; Nakagawasai O; Takahashi K; Nemoto W; Sakuma W; Lin JR; Tan-No K
    Neuropharmacology; 2019 May; 150():121-133. PubMed ID: 30914305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AICAR prolongs corneal allograft survival via the AMPK-mTOR signaling pathway in mice.
    Jiang L; Liu T; Xie L; Ouyang C; Ji J; Huang T
    Biomed Pharmacother; 2019 May; 113():108558. PubMed ID: 30856534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age-Dependent Changes in AMPK Metabolic Pathways in the Lung in a Mouse Model of Hemorrhagic Shock.
    Klingbeil LR; Kim P; Piraino G; O'Connor M; Hake PW; Wolfe V; Zingarelli B
    Am J Respir Cell Mol Biol; 2017 May; 56(5):585-596. PubMed ID: 28085510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-specific regulation of iNOS by AMP-activated protein kinase in primary rat hepatocytes.
    Zhang B; Lakshmanan J; Du Y; Smith JW; Harbrecht BG
    J Surg Res; 2018 Jan; 221():104-112. PubMed ID: 29229115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel anti-inflammatory action of 5-aminoimidazole-4-carboxamide ribonucleoside with protective effect in dextran sulfate sodium-induced acute and chronic colitis.
    Bai A; Yong M; Ma AG; Ma Y; Weiss CR; Guan Q; Bernstein CN; Peng Z
    J Pharmacol Exp Ther; 2010 Jun; 333(3):717-25. PubMed ID: 20237071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation.
    Ishii N; Matsumura T; Kinoshita H; Motoshima H; Kojima K; Tsutsumi A; Kawasaki S; Yano M; Senokuchi T; Asano T; Nishikawa T; Araki E
    J Biol Chem; 2009 Dec; 284(50):34561-9. PubMed ID: 19843515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-dependent cardiac function during experimental sepsis: effect of pharmacological activation of AMP-activated protein kinase by AICAR.
    Inata Y; Piraino G; Hake PW; O'Connor M; Lahni P; Wolfe V; Schulte C; Moore V; James JM; Zingarelli B
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H826-H837. PubMed ID: 29979626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys.
    Zhao J; Miyamoto S; You YH; Sharma K
    Am J Physiol Renal Physiol; 2015 May; 308(10):F1167-77. PubMed ID: 25428125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isobutyrylshikonin inhibits lipopolysaccharide-induced nitric oxide and prostaglandin E2 production in BV2 microglial cells by suppressing the PI3K/Akt-mediated nuclear transcription factor-κB pathway.
    Jayasooriya RG; Lee KT; Kang CH; Dilshara MG; Lee HJ; Choi YH; Choi IW; Kim GY
    Nutr Res; 2014 Dec; 34(12):1111-9. PubMed ID: 25454762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
    Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
    [TBL] [Abstract][Full Text] [Related]  

  • 60. AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells.
    Jia F; Wu C; Chen Z; Lu G
    Cardiovasc Drugs Ther; 2011 Feb; 25(1):21-9. PubMed ID: 21258964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.